Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Learning Disabilities01:25

Learning Disabilities

213
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
213

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.

Journal of neurology·2026
Same author

Turkish adaptation and psychometric testing of the Perceived Workplace Support Scale in people with inflammatory arthritis.

Rheumatology advances in practice·2026
Same author

Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study.

Neurology and therapy·2026
Same author

Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

Neurology and therapy·2026
Same author

The construct validity of real-world digital mobility outcomes in people with COPD.

ERJ open research·2026

相关实验视频

Updated: Jul 19, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K

在多发性硬化症中测量残疾:WHODAS 2.0

Carolyn A Young1,2, David J Rog3, Basil Sharrack4

  • 1Walton Centre NHS Foundation Trust, Lower Lane, Fazakerley, Liverpool, L9 7LJ, UK. Carolyn.young11@nhs.net.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
|August 17, 2023
PubMed
概括

世界卫生组织残疾评估表2.0 (WHODAS 2.0) 可靠地测量了多发性硬化症 (MS) 的残疾. 这种患者报告的结果对于在临床和研究环境中跟踪MS残疾轨迹非常有价值.

关键词:
评估评估的方法障碍障碍是指残疾人的残疾.多发性硬化症是多发性硬化症.患者报告的结果衡量结果.拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什拉什神经疾病的结果轨迹 (TONiC)世界卫生组织残疾评估时间表2.0

更多相关视频

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.1K
Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

9.2K

相关实验视频

Last Updated: Jul 19, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.1K
Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

9.2K

科学领域:

  • 神经学 神经学
  • 康复医学 康复医学 康复医学
  • 心理测量 心理测量 心理测量

背景情况:

  • 可靠的患者自我报告残疾测量对于多发性硬化症 (MS) 研究和临床实践至关重要.
  • 世界卫生组织残疾评估表2.0 (WHODAS 2.0) 是评估残疾的综合工具.

研究的目的:

  • 评估WHODAS 2.0在大量多发性硬化症患者中的心理特征.
  • 确定不同的WHODAS 2.0版本的可靠性和有效性,用于个人和小组评估.

主要方法:

  • 拉什分析应用于5809名多发性硬化患者的数据,用于神经条件-MS研究结果轨迹的研究.
  • 评估了WHODAS 2.0 (36项,32项和12项简短形式) 的可靠性,有效性和差异性项目功能 (DIF).

主要成果:

  • 36项和32项的WHODAS 2.0表格及其认知和物理领域,证明了对个人和团体使用的可靠测量.
  • 12项简单表格仅适用于小组评估.
  • 所有尺度都提供了区间级数据,在各种人口和疾病特征上进行了显著的歧视,并且显示了最小的DIF,支持纵向使用.

结论:

  • "WHODAS 2.0"是一个有效可靠的仪器,用于在间隔水平上测量和监测多发性硬化症中的残疾.
  • 在临床和研究环境中例行实施WHODAS 2.0可以对MS残疾轨迹产生重大见解.